Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Photobiotics logo — Innovative solutions for precise MRI imaging and cancer trea...

Photobiotics

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and light-activated therapies

Founded 2001 1 employees Venture round Total: $390.00K Biotechnology, Life Sciences +1

General Information

Company Name Photobiotics
Founded Year 2001
Employees 1
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Photobiotics. To contact Photobiotics, visit photobiotics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Photobiotics compare?

A PDF of Photobiotics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Photobiotics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Photobiotics

Photobiotics is a biotechnology and pharmaceutical startup founded in 2001, focusing on developing innovative solutions for precise MRI imaging and cancer treatment. Their flagship product, OptiLink, is a platform designed to attach multiple drugs to antibody fragments, thereby enhancing drug delivery for both imaging and therapy purposes. Furthermore, they have a diverse portfolio that includes antibody-drug conjugates and ProstaLite, a targeted light-activated solution for cancer therapy. The company recently secured a £390.00KVenture Round investment on 11 May 2010, signaling investor confidence in their pioneering approach to cancer treatment and imaging technologies. Photobiotics’ ability to leverage advanced drug delivery mechanisms and light-activated therapies aligns with the growing demand for more effective and precise solutions in the field of oncology and medical imaging. Their commitment to developing specialized therapies demonstrates potential for addressing critical challenges in cancer treatment, potentially positioning them as a valuable player in the pharmaceutical and biotechnology industries. With the continued support of investors, Photobiotics has the opportunity to further advance their innovative solutions and solidify their presence in the market.

Business keywords: MRI imaging, cancer treatment, drug delivery, antibody fragments, therapeutics, conjugation platform, targeted therapies, antibody-drug conjugates, light-activated therapy, precision medicine, oncology, biopharmaceuticals, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £390.00K -
11 May 2010

Photobiotics Alternatives & Competitors

View All Alternatives
Photobiotics vs
Endocyte
Endocyte United States

Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personal...

Debt Financing
16 employees
Biotechnology, Health Care
Photobiotics vs
ImCheck Therapeutics
ImCheck Therapeutics France

Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic

Grant
57 employees
Biopharma, Biotechnology
Photobiotics vs
BioInvent International AB
BioInvent International AB Sweden

BioInvent is developing the next-generation of cancer immunotherapy.

IPO
133 employees
Biotechnology, Health Care
Also compare with: Photobiotics vs Tagworks Pharmaceuticals Tagworks Pharmaceuticals View all alternatives

FAQ About Photobiotics

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and light-activated therapies
Photobiotics was founded in 2001.
Photobiotics operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on MRI imaging, cancer treatment, drug delivery and antibody fragments.
Photobiotics has approximately 1 employees.
Photobiotics has completed 1 funding round, raising a total of $390.00K. The latest funding stage is Venture round.
Top alternatives and competitors to Photobiotics include Endocyte, ImCheck Therapeutics, BioInvent International AB, Bound Therapeutics, Theramir Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Photobiotics and Endocyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Photobiotics, https://bouncewatch.com/company/photobiotics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout